HMG-CoA reductase is a crucial enzyme in the mevalonate pathway, responsible for catalyzing the conversion of HMG-CoA to mevalonate, a key step in cholesterol biosynthesis. It is the primary target of statins, a class of drugs used to lower cholesterol levels and reduce the risk of cardiovascular disease.